Leon Jonathan A 4
Research Summary
AI-generated summary
Accendra Health (ACH) EVP/CFO Leon Jonathan Receives Award
What Happened
- Leon Jonathan A, EVP & Chief Financial Officer of Accendra Health (ACH), was granted 85,067 restricted shares on 2026-03-09. The shares were issued at $0.00 (no cash paid); total reported acquisition value $0. This transaction is an award (Form 4 code A), not an open‑market purchase or sale.
Key Details
- Transaction date: 2026-03-09; filing date: 2026-03-10.
- Shares granted: 85,067 restricted shares; price per share reported: $0.00; total reported value: $0.
- Vesting: Grant vests one‑third per year over three years (footnote).
- Shares owned after the transaction: Not specified in the information provided on this Form 4.
- No indication of a 10b5‑1 plan, tax withholding, or immediate sale in the filing.
- Filing appears timely (filed the day after the transaction).
Context
- Restricted stock grants are commonly used for executive compensation and retention; they typically vest over time and align executives’ interests with shareholders but do not by themselves indicate a buy or sell sentiment.
- Because this was an award (no cash paid and no immediate sale), there was no immediate change to market float from this transaction.